COVID-19 Outbreak-Global Glaucoma Treatment Drugs Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
By Maia Research | Pharmaceuticals and Healthcare | Aug 2020 | Page 104
Glaucoma is a disease characterized by fluid builds up in the front part of your eye which results in damages to the eyes optic nerve which may lead to blindness....
COVID-19 Outbreak-Global Riociguat Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
By Maia Research | Pharmaceuticals and Healthcare | Aug 2020 | Page 111
The Riociguat market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025. Under COVID-19 outbreak globally, this report....
COVID-19 Outbreak-Global Pegfilgrastim Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
By Maia Research | Pharmaceuticals and Healthcare | Aug 2020 | Page 105
Pegfilgrastim is a long-acting version of filgrastim and may be prescribed to appropriate cancer patients undergoing chemotherapy to enhance the production of infection-fighting white blood cells. The Pegfilgrastim market revenue was....
COVID-19 Outbreak-Global Cervical Cancer Screening Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
By Maia Research | Pharmaceuticals and Healthcare | Aug 2020 | Page 117
The Cervical Cancer Screening market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025. Under COVID-19 outbreak globally,....
COVID-19 Outbreak-Global Botulinum Toxins Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
By Maia Research | Pharmaceuticals and Healthcare | Aug 2020 | Page 114
Botulinum toxin (BTX) is a neurotoxic protein produced by the bacterium Clostridium botulinum and related species.It prevents the release of the neurotransmitter acetylcholine from axon endings at the neuromuscular junction....